How a presidential hoax unfolded on social media
UC expert discusses why some conspiracy theories get attention
National news media turned to a University of Cincinnati expert on conspiracy theories to explain why rumors about President Trump's health over Labor Day weekend captured public attention.
Social media posts trended with false reports of the president's passing. The hoax made it back to the White House on Tuesday when Fox News asked the president, “How did you find out over the weekend that you were dead?”
UC Professor Jeffrey Blevins said one thing that fanned the fire of conspiracy was a comment Vice President J.D. Vance made that was shared out of context on social media.
USA Today asked Vance if he was prepared to assume the duties of president, given Trump's age at 79.
Blevins told PolitiFact that Vance's comments were innocuous, but in combination with speculation about the president's health and his nonpublic weekend schedule "gives spark to these (kinds) of ideas.”
Blevins also told the nonprofit Poynter Institute that what distinguished the latest hoax was how widely it was shared on social media. The claims reached millions of people.
Blevins teaches in UC's School of Public and International Affairs. He studies misinformation and the way conspiracy theories take hold. He is co-author of the 2024 book “Social Media and Digital Politics: Networked Reason in an Age of Digital Emotion.”
MSN and PBS NewsHour shared the PolitiFact story.
Related Stories
Bearcat Mascot, Cheer Team and scholarships help celebrate Decision Day
December 12, 2025
Cincinnati media organization provided news coverage of Decision Day activities at the University of Cincinnati on Dec. 10, 2025. Surprise announcements of the 2026 Marian Spencer Scholarship recipient occurred during the day.
The legacy of Cincinnati bootlegger George Remus
December 11, 2025
WLWT Journalist Lindsay Stone spoke with Christopher Bryant, a professor in University of Cincinnati College of Law, about the legal troubles of Cincinnati bootlegger George Remus.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.